Apr 17, 2025 · Anonymous board for Novartis.Promote your message to our pharma audience. Board-level targeting available.

Dec 22, 2025 · Novartis (NVS) has received FDA approval for Itvisma, a groundbreaking gene therapy for spinal muscular atrophy (SMA). Itvisma is the first therapy targeting the genetic …

Aug 20, 2020 · Novartis will have to wait a little longer to see if the U.S. Food and Drug Administration (FDA) will greenlight Arzerra (ofatumumab) as a treatment for patients with …

Mar 4, 2025 · Xolair, a 20-year-old asthma drug sold by Roche (ROG.S) and Novartis (NOVN.S) significantly reduced allergic reactions in people with multiple severe food allergies in a late …

Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales

Oct 27, 2025 · Novartis shares slip, Avidity soars after $12 billion biotech dealNovartis boardInnovent, Lilly's mazdutide trumps Novo's semaglutide in head-to-head diabetes, weight …

Jul 17, 2025 · In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO Vas Narasimhan told reporters that for most …

Sep 23, 2025 · Novartis is discontinuing the development of the anti-TGFβ antibody NIS793 and is returning it to Xoma Corporation, according to an SEC filing posted Friday. Following the …

Jul 25, 2025 · Ribon Therapeutics has named Sudha Parasuraman as its CMO. Parasuraman, last seen occupying the same role at X4 Pharmaceuticals, joins Ribon as it works to use …

May 2, 2022 · snippet Novartis' CEO has stated he is looking in the small-cap space for acquisition targets. Two companies that could be potential candidates are innovators in the …